Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.40
Bid: 48.90
Ask: 49.15
Change: -0.15 (-0.30%)
Spread: 0.25 (0.511%)
Open: 49.30
High: 49.40
Low: 49.30
Prev. Close: 49.55
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

14 Mar 2024 07:00

RNS Number : 7646G
IP Group PLC
14 March 2024
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 18th December 2023 (the Buyback Programme).

Date of purchase:

13/03/2024

Number of ordinary shares purchased:

350,000

Highest price paid per ordinary share (GBp):

50.40

Lowest price paid per ordinary share (GBp): 

48.60

Volume weighted average price paid per ordinary share (GBp): 

49.7008

 

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 31, 957,873 of its ordinary shares in treasury and has 1,063,188,005 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,031,230,132 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

13/03/2024

Number of ordinary shares purchased:

350,000

Volume weighted average price (pence):

49.7008

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

2856

50.00

 13:14:57

XLON

8

50.20

 13:32:30

XLON

2626

50.20

 13:32:30

XLON

119

50.20

 13:32:30

XLON

603

50.20

 13:32:30

XLON

1670

50.20

 13:32:30

XLON

2551

50.20

 13:32:30

XLON

7706

50.20

 13:32:30

XLON

15939

50.20

 13:32:30

XLON

9241

50.10

 13:32:31

XLON

9539

50.00

 13:32:34

XLON

3440

50.00

 13:44:01

XLON

1038

50.00

 13:45:41

XLON

5830

50.00

 13:45:41

XLON

6312

50.00

 13:45:41

XLON

2845

50.00

 13:46:17

XLON

3372

50.00

 13:46:17

XLON

6

50.00

 13:46:17

XLON

3687

50.00

 13:46:17

XLON

8342

50.00

 13:49:32

XLON

2162

49.90

 13:55:41

XLON

1981

49.90

 13:55:43

XLON

5580

49.90

 13:55:43

XLON

2367

49.90

 14:04:30

XLON

6067

49.90

 14:04:30

XLON

1800

50.00

 14:11:17

XLON

1031

50.20

 14:17:36

XLON

1437

50.20

 14:17:36

XLON

1082

50.20

 14:17:36

XLON

1500

50.10

 14:17:36

XLON

8045

50.10

 14:25:01

XLON

8956

50.10

 14:25:01

XLON

123

50.40

 14:33:13

XLON

284

50.40

 14:33:13

XLON

1397

50.40

 14:33:13

XLON

1801

50.40

 14:33:13

XLON

6686

50.40

 14:33:13

XLON

884

50.40

 14:33:13

XLON

8266

50.40

 14:33:13

XLON

1648

50.30

 14:34:55

XLON

6908

50.30

 14:34:55

XLON

12302

50.10

 14:52:18

XLON

8273

50.10

 14:52:18

XLON

2296

50.10

 14:53:18

XLON

7495

50.10

 14:53:18

XLON

50

50.00

 14:56:03

XLON

912

50.00

 14:56:03

XLON

8328

49.85

 14:57:19

XLON

4900

49.95

 14:57:19

XLON

2947

49.95

 14:57:19

XLON

438

50.00

 14:57:19

XLON

9310

49.90

 15:09:51

XLON

10000

50.00

 15:09:51

XLON

1260

50.00

 15:09:51

XLON

9007

49.55

 15:22:53

XLON

9204

49.35

 15:24:02

XLON

4515

49.25

 15:32:02

XLON

3676

49.25

 15:32:02

XLON

428

49.25

 15:32:02

XLON

3744

49.15

 15:34:20

XLON

4387

49.15

 15:35:14

XLON

9981

49.00

 15:46:42

XLON

9399

49.00

 15:46:42

XLON

3600

49.15

 15:51:24

XLON

4415

49.15

 15:51:24

XLON

679

49.15

 15:51:24

XLON

5429

49.10

 15:56:24

XLON

3093

49.10

 15:56:24

XLON

6331

48.80

 16:04:55

XLON

1903

48.80

 16:04:55

XLON

1652

48.80

 16:04:55

XLON

5060

48.80

 16:05:55

XLON

4064

48.80

 16:05:55

XLON

5059

48.80

 16:09:11

XLON

4153

48.80

 16:09:11

XLON

4041

48.80

 16:13:11

XLON

5249

48.80

 16:13:11

XLON

5662

48.60

 16:19:01

XLON

4459

48.60

 16:19:01

XLON

814

48.60

 16:19:43

XLON

3750

48.60

 16:19:43

XLON

 

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZGMFNFVGDZM
Date   Source Headline
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc
5th Aug 20207:00 amRNSHalf-yearly results
3rd Aug 20207:00 amRNSNanopore partners with govt on covid-19 test
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.